64 related articles for article (PubMed ID: 2195449)
1. [Therapeutic potential of ofloxacin in hospital medicine. A French multicenter study].
Carbon C; Delval C
Pathol Biol (Paris); 1990 May; 38(5):397-400. PubMed ID: 2195449
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
3. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
[TBL] [Abstract][Full Text] [Related]
5. [Specificity of the anaerobic bacterial infections in the surgical and orthopedic wards].
Kierzkowska M; Majewska A; Sawicka-Grzelak A; Młynarczyk A; Ładomirska-Pestkowska K; Młynarczyk G
Med Dosw Mikrobiol; 2012; 64(1):29-34. PubMed ID: 22808727
[TBL] [Abstract][Full Text] [Related]
6. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
Dai CM; Zhou JD; Wu Y; Qi Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
[TBL] [Abstract][Full Text] [Related]
7. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
[TBL] [Abstract][Full Text] [Related]
9. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
10. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P
Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711
[TBL] [Abstract][Full Text] [Related]
13. [Differences between species involved and fluoroquinolone resistance patterns of strains isolated from bacteriuria according to nosocomial, health-related or community-acquired onset].
Tassain J; N'Guyen Y; Batalla AS; Duval V; Guillard T; De Champs C; Strady C
Presse Med; 2012 Dec; 41(12 Pt 1):e586-93. PubMed ID: 22727916
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
15. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.
Wisplinghoff H; Seifert H; Tallent SM; Bischoff T; Wenzel RP; Edmond MB
Pediatr Infect Dis J; 2003 Aug; 22(8):686-91. PubMed ID: 12913767
[TBL] [Abstract][Full Text] [Related]
19. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
Nikodemski T
Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
[TBL] [Abstract][Full Text] [Related]
20. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]